Lv6
2440 积分 2024-09-23 加入
Ten unanswered questions about dipeptidyl peptidase-1 inhibition in bronchiectasis
7天前
已完结
Clearing the air: Clarifying data and interpretations from the ASPEN trial of brensocatib in bronchiectasis
7天前
已完结
[China lymphoma diagnosis and treatment guideline (2026 edition)]
1个月前
已完结
Diffuse Large B-Cell Lymphoma
1个月前
已完结
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
1个月前
已完结
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II
2个月前
已完结
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II
2个月前
已完结
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial
2个月前
已完结
Surrogate end points in oncology: aligning drug development incentives and patient needs
2个月前
已关闭
Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development
2个月前
已完结
皖公网安备34019202002308
